Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Net Cash Flow (2021 - 2025)

Historic Net Cash Flow for Rxo (RXO) over the last 5 years, with Q4 2025 value amounting to -$8.0 million.

  • Rxo's Net Cash Flow rose 5555.56% to -$8.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$19.0 million, marking a year-over-year decrease of 15937.5%. This contributed to the annual value of -$19.0 million for FY2025, which is 15937.5% down from last year.
  • Rxo's Net Cash Flow amounted to -$8.0 million in Q4 2025, which was up 5555.56% from $7.0 million recorded in Q3 2025.
  • Over the past 5 years, Rxo's Net Cash Flow peaked at $166.0 million during Q2 2022, and registered a low of -$100.0 million during Q4 2023.
  • Over the past 5 years, Rxo's median Net Cash Flow value was $500000.0 (recorded in 2021), while the average stood at -$687500.0.
  • Per our database at Business Quant, Rxo's Net Cash Flow plummeted by 860000.0% in 2022 and then soared by 35263.16% in 2024.
  • Over the past 5 years, Rxo's Net Cash Flow (Quarter) stood at -$1.0 million in 2021, then plummeted by 8600.0% to -$87.0 million in 2022, then decreased by 14.94% to -$100.0 million in 2023, then surged by 82.0% to -$18.0 million in 2024, then soared by 55.56% to -$8.0 million in 2025.
  • Its Net Cash Flow was -$8.0 million in Q4 2025, compared to $7.0 million in Q3 2025 and $2.0 million in Q2 2025.